載入...
Does mutated K-RAS oncogene attenuate the effect of Sulindac in colon cancer chemoprevention?
The non-steroidal anti-inflammatory drug (NSAID) Sulindac has been successfully used alone or in combination with other agents to suppress colon tumorigenesis in patients with genetic predisposition, and also showed its efficacy in prevention of sporadic colon adenomas. At the same time, some experi...
Na minha lista:
| 發表在: | Cancer Prev Res (Phila) |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7733710/ https://ncbi.nlm.nih.gov/pubmed/29118162 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-17-0230 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|